The concentrations of other parameters (CCL11, CCL26, CXCL14 and CA 19-9) were comparable to or even lower in the sera of patients with colorectal cancer compared to the group of healthy volunteers [8,9,10]. This evidence concerns the gene CCL26 and colorectal cancer.